SCHEMBL19943434

SCHEMBL19943434

COc1cc(OC)c(C)c(-c2ccc3nc(N)ncc3c2)c1C

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 15/20 0.53
▸ KDR P35968 8/20 0.53
▸ JAK3 P52333 2/20 0.53
▸ MAPK14 Q16539 1/20 0.53
▸ KIT P10721 14/20 0.53
▸ SRC P12931 14/20 0.53
▸ FGFR4 P22455 2/20 0.50
▸ JAK2 O60674 1/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ DHFR P00374 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21153337 0.94 FGFR4 (0.57) LCKKDRJAK3MAPK14KIT
SCHEMBL21153989 0.89 LCK (0.47) LCKKDRJAK3MAPK14KIT
SCHEMBL16676911 0.88 FGFR4 (0.66) LCKKDRJAK3MAPK14KIT
SCHEMBL22781316 0.86 FGFR4 (0.52) LCKKITSRCFGFR4
SCHEMBL5489026 0.84 LCK (0.55) LCKKDRJAK3MAPK14KIT
SCHEMBL21154059 0.83 FGFR4 (0.56) FGFR4
SCHEMBL21153647 0.80 FGFR4 (0.54) LCKKDRJAK3MAPK14KIT
SCHEMBL21154002 0.80 FGFR4 (0.60) FGFR4
SCHEMBL21153921 0.80 FGFR4 (0.60) FGFR4
SCHEMBL22781190 0.80 FGFR4 (0.56) LCKKITSRCFGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508482-B1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF NANJING TRANSTHERA BIOSCIENCES CO LTD (CN) 2020-12-16 — — EP disclosed
EP-3508482-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF Nanjing Transthera Biosciences Co. Ltd. (CN) 2019-07-10 — — EP disclosed
WO-2018040885-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF 南京药捷安康生物科技有限公司 2018-03-08 — — WO disclosed
Send feedback